3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Tuberous Sclerosis
1
Smoldering Multiple Myeloma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Disease
1
Interventions
Sirolimus
6
Everolimus
5
saracatinib
1
nintedanib
1
Urination
1
Sugars
1
Simvastatin
1
Resveratrol
1
Octreotide
1
Letrozole
1
Imatinib Mesylate
1
Hydroxychloroquine
1
Glutamine
1
Doxycycline
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphangioleiomyomatosis
×
Urination
×
Clear all
NCT05323370
2023-03-29
LAM-CAK
University Hospital, Tours
Completed
19 enrolled